A COMPARISON OF GONADOTROPIN RELEASING HORMONE AGONIST (GnRHa) AND HUMAN CHORIONIC GONADOTROPIN (hCG) FOR FINAL OOCYTE MATURATION IN AN EGG DONOR POPULATION.

被引:1
|
作者
Morin, S. J. [1 ]
McCulloh, D. H. [2 ]
Licciardi, F. [2 ]
机构
[1] NYU, Langone Med Ctr, New York, NY USA
[2] NYU, Fertil Ctr, New York, NY USA
关键词
D O I
10.1016/j.fertnstert.2013.07.1107
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
P-404
引用
收藏
页码:S264 / S264
页数:1
相关论文
共 50 条
  • [1] Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles
    Shapiro, Bruce S.
    Daneshmand, Said T.
    Garner, Forest C.
    Aguirre, Martha
    Ross, Richard
    FERTILITY AND STERILITY, 2007, 88 (01) : 237 - 239
  • [2] Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program
    Erb, Teresa M.
    Vitek, Wendy
    Wakim, Anthony N. G.
    FERTILITY AND STERILITY, 2010, 93 (02) : 374 - 378
  • [3] Dual trigger with gonadotropin-releasing hormone agonist (GnRHa) and standard dose of human chorionic gonadotropin (hCG) to improve oocyte maturation rate (MR)
    Elkouhen, I.
    Herbemont, C.
    Brax, A.
    Comtet, M.
    Sarandi, S.
    Seroka, A.
    Dagher-Hayeck, B.
    Boujenah, J.
    Vinolas, C.
    Grynberg, M.
    Cedrin-Durnerin, I.
    Sifer, C.
    HUMAN REPRODUCTION, 2018, 33 : 460 - 461
  • [4] DUAL TRIGGER WITH GONADOTROPIN RELEASING HORMONE AGONIST (GnRHa) AND HUMAN CHORIONIC GONADOTROPIN (HCG) FOR THE TREATMENT OF 'IMMATURE OOCYTE SYNDROME' (IOS)
    Griffin, D.
    Engmann, L.
    Budinetz, T.
    Kummer, N.
    Nulsen, J.
    Benadiva, C.
    FERTILITY AND STERILITY, 2012, 98 (03) : S156 - S156
  • [5] Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience
    Jhansi Reddy
    Volkan Turan
    Giuliano Bedoschi
    Fred Moy
    Kutluk Oktay
    Journal of Assisted Reproduction and Genetics, 2014, 31 : 927 - 932
  • [6] DUAL TRIGGER OF OOCYTE MATURATION WITH GONADOTROPIN RELEASING HORMONE AGONIST (GnRHa) AND LOW DOSE HUMAN CHORIONIC GONADOTROPIN (hCG) TO OPTIMIZE CONCEPTION RATES IN HIGH RESPONDERS
    Griffin, D. W.
    Benadiva, C. A.
    Kummer, N. E.
    Elassar, A. A.
    Nulsen, J. C.
    Engmann, L. L.
    FERTILITY AND STERILITY, 2011, 96 (03) : S20 - S21
  • [7] Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience
    Reddy, Jhansi
    Turan, Volkan
    Bedoschi, Giuliano
    Moy, Fred
    Oktay, Kutluk
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (07) : 927 - 932
  • [8] Final Oocyte Maturation in Assisted Reproduction with Human Chorionic Gonadotropin and Gonadotropin- releasing Hormone agonist (Dual Trigger)
    de Oliveira, Sofia Andrade
    Calsavara, Vincius Fernando
    Castillon Cortes, Gemma
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2016, 20 (04): : 246 - 250
  • [9] Gonadotropin Releasing Hormone Agonist Final Oocyte Maturation and Human Chorionic Gonadotropin as Exclusive Luteal Support in Normal Responders
    Beck-Fruchter, Ronit
    Baram, Shira
    Geslevich, Yoel
    Weiss, Amir
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2019, 84 (01) : 27 - 34
  • [10] TWO TYPES OF DIFFERENT FORMULATION OF GONADOTROPIN-RELEASING HORMONE AGONIST OR HUMAN CHORIONIC GONADOTROPIN RECOMBINANT (r-hCG) FOR FINAL OOCYTE MATURATION IN DONOR CYCLES.
    Torno, A. L.
    Ferle, L.
    Canada, V. E.
    Salama, E. A.
    FERTILITY AND STERILITY, 2012, 98 (03) : S265 - S266